Tech Transfer

Find out more about our patent portfolio and intellectual property.

Tech Transfer

Tech Transfer

Find out more about our patent portfolio and intellectual property.


The Diabetes Research Group has made a number of research discoveries leading to development of a strong patent portfolio and intellectual property for commercialisation through Innovation Ulster and the establishment of Diabetica Limited.

The establishment of Diabetica Limited was formed by the academic co-founders Professor Peter Flatt, Dr Neville McClenaghan and Professor Finbarr O'Harte.

The co-founders won the prestiguous inaugural ACES Academic Enterprise Award for Innovation in Life Sciences in Stockholm in 2008

The Group contributed two impact case studies in REF2014:

  1. Generation of peptide therapeutics for industry
  2. Development and commercialisation of human clonal beta cells for end-user communities.